4th Quarter - Report

THE OB-C GROUP, LLC for EMERGENT BIOSOLUTIONS INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

HR 3304: The National Defense Authorization Act; matters relating to chemical decontamination.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3304 (113th)

Budget/Appropriations BUD

HR 2217: Dept. Of Homeland Security Appropriations Act of 2014; matters relating to the Biomedical Advanced Research & Development Authority (BARDA) and Project Bioshield relating to stockpiling of biodefense vaccines. No specific bill number: Dept. Health and Human Services and Related Agencies Appropriations Act, 2014; matters relating to WMD Prevention and Preparedness Act; provisions relating to development, acquisition and stockpiling of biodefense vaccines.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2217 (113th)

Homeland Security HOM

No specific bill number: matters relating to development, acquisition, and stockpiling of biodefense vaccines.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.